HoyleCohen’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

HoyleCohen’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-650	Closed	-$5.59K	–	303
2024 Q1	$5.59K	Hold	650	–	–	﹤0.01%	282
2023 Q4	$2.28K	Hold	650	–	–	﹤0.01%	271
2023 Q3	$2.31K	Hold	650	–	–	﹤0.01%	260
2023 Q2	$3.78K	Hold	650	–	–	﹤0.01%	261
2023 Q1	$24.6K	Hold	650	–	–	﹤0.01%	257
2022 Q4	$19.4K	Hold	650	–	–	﹤0.01%	264
2022 Q3	$22K	Hold	650	–	–	﹤0.01%	256
2022 Q2	$26K	Hold	650	–	–	﹤0.01%	258
2022 Q1	$34K	Hold	650	–	–	﹤0.01%	272
2021 Q4	$36K	Hold	650	–	–	﹤0.01%	275
2021 Q3	$50K	Hold	650	–	–	﹤0.01%	266
2021 Q2	$84	Hold	650	–	–	0.01%	264
2021 Q1	$107K	Hold	650	–	–	0.01%	263
2020 Q4	$152K	Buy	650 +50	+8%	+$6.96K	0.02%	218
2020 Q3	$62K	Buy	+600	New	+$32.1K	0.01%	204

Other funds holding TCON

GPFA

Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return

HoyleCohen's TCON Position: Q2 2024 in Review

HoyleCohen sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 650 shares — an estimated $5.59K sold.

HoyleCohen first reported a position in TCON in Q3 2020 and held it in 15 quarters. The position peaked at $152K in Q4 2020. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

HoyleCohen reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
HoyleCohen sold 650 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $5.59K.
HoyleCohen first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
HoyleCohen's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $152K in Q4 2020.
1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.